Literature DB >> 932641

Genetic control of specific immune suppression. III. Mapping of H-2 complex complementing genes controlling immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT).

P Debré, C Waltenbaugh, M Dorf, B Benacerraf.   

Abstract

Earlier studies from our laboratory demonstrated that the terpolymer of L-glutamic acid, L-alanine, and L-tyrpsine (GAT) stimulated the development of T cells capable of specifically suppressing the antibody responses in vivo and in vitro of nonresponder strains (bearing the H-2(s), H-2(q), and H-2(p) haplotypes) to GAT complexed with an immunogenic carrier, methylated bovine serum albumin, MBSA (1,2). We then extended these findings to another antigen, the copolymer of L-glutamic acid and L-tyrosine (GT). None of 19 inbred or congenic resistant mouse strains developed antibody responses to GT after immunization with this synthetic polypeptide in adjuvants. All the strains investigated, however, developed IgG plaque-forming cells (PFC) primary responses to GT complexed with MBSA (3). This permitted us to determine that: (a) preimmunization with GT suppressed the response to GT-MBSA in certain but not in all strains; (b) the suppression could be transferred by thymocytes and spleen cells from GT-primed animals; (c) the development of GT-specific suppressor cells is under dominant control of H-2- linked gene(s) which have been designated specific immune suppressor genes (Is genes); (d) the Is genes are antigen specific since GAT-MBSA responses are suppressed by GAT in strains carrying the H-2(q) haplotype, while GT-MBSA responses are not suppressed by the related polymer GT in these same strains (3,4). The experiments reported in this study map the Is genes responsible for GT-specific suppression within the H-2 complex. The data indicate that the K and D loci are not concerned with GT-specific suppression, and that this phenomenon is controlled by complementing or interacting genes which map on either side of cross-over events between the IB and IC subregions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932641      PMCID: PMC2190362          DOI: 10.1084/jem.144.1.272

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Fractionation of nucleic acids with the methylated albumin column.

Authors:  N SUEOKA; T Y CHENG
Journal:  J Mol Biol       Date:  1962-03       Impact factor: 5.469

2.  Complementation of H-2-linked Ir genes in the mouse.

Authors:  M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Genetic control of immune responses in vitro. VI. Experimental conditions for the development of helper T-cell activity specific for the terpolymer L-glutamic aicd60-L-alanine30-L-tyrosine10 (GAT) in nonresponder mice.

Authors:  J A Kapp; C W Pierce; B Benacerraf
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

4.  The requirement for two complementing Ir-GLphi immune response genes in the T-lymphocyte proliferative response to poly-(Glu53Lys36Phe11).

Authors:  R H Schwartz; M E Dorf; B Benacerraf; W E Paul
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

5.  Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.

Authors:  P Debré; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

6.  Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.

Authors:  P Debré; C Waltenbaugh; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

7.  Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.

Authors:  C W Pierce; B M Johnson; H E Gershon; R Asofsky
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

8.  Genetic control of specific immune suppression. II. H-2-linked dominant genetic control of immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT).

Authors:  P Debré; J A Kapp; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

9.  Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT).

Authors:  J A Kapp; C W Pierce; S Schlossman; B Benacerraf
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice.

Authors:  J A Kapp; C W Pierce; B Benacerraf
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

  10 in total
  14 in total

1.  Mechanisms of genetic control of immune responses. II. Nonresponsiveness in BALB/c GT-specific cell-mediated immune responses does not correlate with the absence of functional T cells or the induction of suppressor T cells.

Authors:  M K Kennedy; M K Jenkins; S D Miller
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 2.  Antigen specific T cell factors.

Authors:  M Feldmann; S Kontiainen
Journal:  Mol Cell Biochem       Date:  1980-05-07       Impact factor: 3.396

Review 3.  Helper and suppressor T cell factors.

Authors:  R N Germain; B Benacerraf
Journal:  Springer Semin Immunopathol       Date:  1980-05

4.  Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells.

Authors:  L De Giorgi; A Matossian-Rogers; H Festenstein
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

5.  Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.

Authors:  M Pierres; R N Germain; M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Genetic analysis of immune suppression. I. Gene complementation is required for suppression of antigen-specific proliferative responses by T-cell derived factors.

Authors:  B A Araneo; J A Kapp
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid60-L-alanine30-L-tyrosine10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen.

Authors:  R N Germain; J Thèze; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

8.  Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor.

Authors:  R N Germain; C Waltenbaugh; B Benacerraf
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

9.  H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway.

Authors:  C N Baxevanis; N Ishii; Z A Nagy; J Klein
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

10.  Regulation of immune responses by I-J gene products. II. Presence of Both I-Jb and I-Jk suppressor factors in (nonsuppressor x nonsuppressor) F1 mice.

Authors:  H Y Lei; M E Dorf; C Waltenbaugh
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.